Thompson Rubinstein Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$458K	Hold	9,600	–	–	0.15%	68
2018 Q4	$499K	Hold	9,600	–	–	0.18%	63
2018 Q3	$596K	Hold	9,600	–	–	0.18%	64
2018 Q2	$531K	Hold	9,600	–	–	0.18%	64
2018 Q1	$607K	Hold	9,600	–	–	0.21%	65
2017 Q4	$588K	Hold	9,600	–	–	0.19%	65
2017 Q3	$612K	Hold	9,600	–	–	0.21%	63
2017 Q2	$535K	Hold	9,600	–	–	0.2%	66
2017 Q1	$522K	Hold	9,600	–	–	0.19%	65
2016 Q4	$561K	Hold	9,600	–	–	0.21%	64
2016 Q3	$518K	Hold	9,600	–	–	0.2%	65
2016 Q2	$706K	Hold	9,600	–	–	0.27%	61
2016 Q1	$613K	Hold	9,600	–	–	0.25%	62
2015 Q4	$660K	Hold	9,600	–	–	0.3%	57
2015 Q3	$568K	Hold	9,600	–	–	0.25%	61
2015 Q2	$639K	Hold	9,600	–	–	0.25%	63
2015 Q1	$619K	Hold	9,600	–	–	0.24%	63
2014 Q4	$567K	Hold	9,600	–	–	0.22%	64
2014 Q3	$491K	Hold	9,600	–	–	0.19%	64
2014 Q2	$466K	Hold	9,600	–	–	0.18%	63
2014 Q1	$499K	Hold	9,600	–	–	0.2%	61
2013 Q4	$510K	Sell	9,600 -400	-4%	-$20.4K	0.2%	62
2013 Q3	$463K	Hold	10,000	–	–	0.2%	61
2013 Q2	$447K	Buy	+10,000	New	+$434K	0.2%	61

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Thompson Rubinstein Investment Management's BMY Position: Q1 2019 in Review

Thompson Rubinstein Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2019 at 9,600 shares worth $458K. The position accounts for 0.15% of the portfolio, ranked #68.

Thompson Rubinstein Investment Management first reported a position in BMY in Q2 2013 and has held it in 24 quarters since. The position peaked at $706K in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Thompson Rubinstein Investment Management held 9,600 shares of Bristol-Myers Squibb worth $458K as of Q1 2019.
Thompson Rubinstein Investment Management left its Bristol-Myers Squibb share count unchanged in Q1 2019.
Bristol-Myers Squibb made up 0.15% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #68 holding.
Thompson Rubinstein Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 24 quarters since.
Thompson Rubinstein Investment Management's Bristol-Myers Squibb position peaked at $706K in Q2 2016.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.